|
|
Other links at Articles > Hematology-Oncology |
| 3. |
Provenge Fares OK at CMS Review
|
|
|
Sipuleucel-T (Provenge), a prostate cancer vaccine, received a middling vote of confidence for its on-label use and a thumbs-down vote for its off-label use. Medscape Medical News
|
|
|